$1.15
+0.01 (+0.88%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,774.8% upside
Low Target
$28.75
Average Target
$44.56
High Target
$50.07
Current Price
$1.15
Current
$1.15
$1.15
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Scenario Analysis
Bear Case
$28.75
2,400.0%
Low target
Base Case
$44.56
+3,774.8%
Avg target
Bull Case
$50.07
+4,253.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.19
-3.4% from high
52-Week Low
$0.54
+114.6% from low
Target vs 52W High
$44.56
+3,644.5% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-0.12
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals